Cadence Pharmaceuticals

Acquired

San Diego, United States · $86.6M raised

Employees
51–200
Business Model
B2B
Total Funding
$86.6M
Last Round
$86.6M Series AFeb 2009
Rounds
1
Acquisition Date
Feb 2014

About

Cadence Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on developing and commercializing products for use in the hospital setting, primarily targeting acute pain management. The company's lead product was Ofirmev (IV acetaminophen). Cadence raised approximately $197 million in funding before being acquired by Mallinckrodt PLC in 2014 for approximately $1.3 billion.

Summary

Cadence Pharmaceuticals is a Biopharmaceutical company based in San Diego, United States. It has raised $86.6M in total across 1 round, most recently a $86.6M Series A round in Feb 2009. Investors include Venrock, Frazier Healthcare and Domain Associates.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionFeb 2014
$1.2B

Sign up to see all 3 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cadence Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/cadence-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/cadence-pharmaceuticals" alt="Cadence Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>